CD8A and neoplasm: Moreover, a significantly lower percentage of Treg populations in both spleen and tumor as well as higher ratio (p < 0.01) of CD8+ effector T cells to Treg cells were observed after treatment with IMT‐loaded tLyp1‐hNPs, indicating the enhanced cytotoxic CD8+ T cell activation.